Biblio

Author Title [ Type

] Year

Filters: Author is Duval, Michel [Clear All Filters]

Journal Article

Poirier N, Paquin V, Leclerc S, Lisi V, Marmolejo C, Affia H, Cordeiro P, Théorêt Y, Haddad E, Andelfinger G, et al. Therapeutic Inducers of Natural Killer cell Killing (ThINKK): preclinical assessment of safety and efficacy in allogeneic hematopoietic stem cell transplant settings. J Immunother Cancer. 2024;12(5).

Crisinel PAlex, Duval M, Crisinel DThuillard, Mallette B, Bellier N, Vachon M-F, Dedeken L, Rousseau C, Tapiero B, Ovetchkine P. Risk of cytomegalovirus infection and disease after umbilical cord blood transplantation in children. Can J Infect Dis Med Microbiol. 2013;24(1):e11-5.

Bonong PREnok, Buteau C, Duval M, Lacroix J, Laporte L, Tucci M, Robitaille N, Spinella PC, Cuvelier GDE, Lewis V, et al. Risk factors for post-transplant Epstein-Barr virus events in pediatric recipients of hematopoietic stem cell transplants. Pediatr Transplant. 2021:e14052.

Ceppi F, Duval M, Leclerc J-M, Laverdiere C, Delva Y-L, Cellot S, Teira P, Bittencourt H. Improvement of the Outcome of Relapsed or Refractory Acute Lymphoblastic Leukemia in Children Using a Risk-Based Treatment Strategy. PLoS One. 2016;11(9):e0160310.

Ansari M, Uppugunduri CRao S, Ferrari-Lacraz S, Bittencourt H, Gumy-Pause F, Chalandon Y, Tiercy J-M, Schechter T, Gassas A, Doyle JD, et al. The Clinical Relevance of Pre-Formed Anti-HLA and Anti-MICA Antibodies after Cord Blood Transplantation in Children. PLoS One. 2013;8(8):e72141.

Beaufils C, Proulx C, Blincoe A, Teira P, Bittencourt H, Cellot S, Duval M, Morin M-P, De Bruycker JJacques, Couture J, et al. Case report: Success of allogeneic hematopoietic stem cell transplantation for refractory systemic-onset juvenile idiopathic arthritis. Front Med (Lausanne). 2023;10:1275927.